Brinker Capital Investments, LLC Invitae Corp Transaction History

Brinker Capital Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$14.7 - $28.67 $125,229 - $244,239	-8,519 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$26.09 - $40.4 $3,313 - $5,130	127 Added 1.51%	8,519 $287,000
Q1 2021 May 12, 2021	SELL	$33.06 - $56.93 $264,711 - $455,838	-8,007 Reduced 48.83%	8,392 $321,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $322,179 - $473,090	8,242 Added 101.04%	16,399 $686,000
Q3 2020 Dec 03, 2020	BUY	$28.43 - $44.67 $231,903 - $364,373	8,157 New	8,157 $354,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.